Desouza Errol B is a director of Cyclerion Therapeutics Inc.
Person profile
Roles
Address
Paramus, New Jersey
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Alector, Inc.
21 Mar 24
3
Alector, Inc.
21 Mar 24
4
Cyclerion Therapeutics, Inc.
4 Dec 23
4
Royalty Pharma plc
26 Jun 23
4
Royalty Pharma plc
24 Jun 22
4
Cyclerion Therapeutics, Inc.
16 Jun 22
4
CATALYST BIOSCIENCES, INC.
5 Oct 21
4
CATALYST BIOSCIENCES, INC.
2 Jul 21
4
Royalty Pharma plc
29 Jun 21
4
Cyclerion Therapeutics, Inc.
28 Jun 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
19 Mar 24 | ALEC Alector | Common Stock | Grant | Acquire A | No | No | 0 | 41,250 | 0.00 | 41,250 |
19 Mar 24 | ALEC Alector | Stock Option Common Stock | Grant | Acquire A | No | No | 6.2 | 19,420 | 120.40 k | 19,420 |
30 Nov 23 | CYCN Cyclerion Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 30,000 |
30 Nov 23 | CYCN Cyclerion Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 20,000 | 0.00 | 50,000 |
23 Jun 23 | RPRX Royalty Pharma plc - Ordinary Shares | Class A Ordinary Shares | Grant | Acquire A | No | No | 0 | 7,747 | 0.00 | 64,445 |